QUEBEC CITY, March 12, 2013 /CNW Telbec/ - Aeterna Zentaris
Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") will announce
its fourth quarter and full-year 2012 financial and operating
results on Thursday, March 21, 2013,
after market close. The Company will host a conference call the
next morning, Friday, March 22, 2013
at 8:30 a.m. (Eastern Time), to
discuss these results.
Participants may access the live webcast via the Company's
website at www.aezsinc.com in the "Newsroom" section, or by
telephone using the following numbers: in Canada, 514-807-9895 or 647-427-7450, outside
Canada, 888-231-8191. A replay of
the webcast will also be available on the Company's website for a
period of 30 days.
About Aeterna Zentaris
Aeterna Zentaris is an oncology and endocrinology drug
development company currently investigating treatments for various
unmet medical needs. The Company's pipeline encompasses compounds
at all stages of development, from drug discovery through to
marketed products. For more information, please visit
www.aezsinc.com.
SOURCE AETERNA ZENTARIS INC.